Antimicrobial Resistance New Antibiotic Options Show Promise Against Biothreat PathogensGlobal Biodefense StaffSeptember 12, 2025
Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs Medical Countermeasures April 10, 2022 …
Troubling Trends in Physician Vaccine Confidence in the United States Medical Countermeasures April 5, 2022 …
Northwestern University Researchers Develop Nanoparticle Vaccine Platform Medical Countermeasures March 22, 2022 …
CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats CBRNE March 21, 2022 …
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines Medical Countermeasures March 19, 2022 …
Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus Medical Countermeasures March 10, 2022 …
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate Industry News March 3, 2022 …
Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis CBRNE February 27, 2022 …
Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis Antimicrobial Resistance February 17, 2022 …
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense Industry News February 15, 2022 …
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron Medical Countermeasures February 10, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
First Lethal Hamster Model for SARS-CoV-2 Developed by USAMRIID Scientists Medical Countermeasures February 4, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …